Serveur d'exploration sur Pittsburgh

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Histological Predictors of Outcome in Ependymoma are Dependent on Anatomic Site Within the Central Nervous System

Identifieur interne : 006318 ( Main/Merge ); précédent : 006317; suivant : 006319

Histological Predictors of Outcome in Ependymoma are Dependent on Anatomic Site Within the Central Nervous System

Auteurs : Aditya Raghunathan [États-Unis] ; Khalida Wani [États-Unis] ; Terri S. Armstrong [États-Unis] ; Elizabeth Vera-Bolanos [États-Unis] ; Maryam Fouladi ; Richard Gilbertson ; Amar Gajjar ; Stewart Goldman [États-Unis] ; Norman L. Lehman ; Phillipe Metellus [France] ; Tom Mikkelsen ; Mary Jo T. Necesito-Reyes [États-Unis] ; Antonio Omuro [États-Unis] ; Roger J. Packer [États-Unis] ; Sonia Partap ; Ian F. Pollack [États-Unis] ; Michael D. Prados [États-Unis] ; H. Ian Robins ; Riccardo Soffietti [Italie] ; Jing Wu ; C. Ryan Miller ; Mark R. Gilbert [États-Unis] ; Kenneth D. Aldape [États-Unis]

Source :

RBID : ISTEX:5B444A4327C13DDAA09AA7F6A766BDF5A6B00818

Descripteurs français

English descriptors

Abstract

Ependymomas originate in posterior fossa (PF), supratentorial (ST) or spinal cord (SC) compartments. At present, grading schemes are applied independent of anatomic site. We performed detailed histological examination on 238 World Health Organization grade II and III ependymomas. Among PF ependymomas, the presence of hypercellular areas, necrosis, microvascular proliferation and elevated mitotic rate (all P < 0.01) were significantly associated with worse progression‐free survival (PFS), while extensive ependymal canal formation was not (P = 0.89). Similar to the PF tumors, microvascular proliferation (P = 0.01) and elevated mitotic rate (P = 0.03) were significantly associated with worse PFS in the ST tumors. However, in contrast to PF tumors, extensive ependymal canals (P = 0.03) were associated with worse clinical outcome in ST ependymomas, but hypercellularity (P = 0.57) and necrosis (P = 0.47) were not. On multivariate Cox regression, after adjusting for relevant clinical variables, individual histological factors and a composite histological score remained significant among ST and PF ependymoma. In contrast to both PF and ST ependymoma, histological features were not found to be associated with PFS in SC tumors. Taken together, the clinical relevance of specific histological features in ependymoma appears to be related to the anatomic site of origin and suggests that site‐specific grading criteria be considered in future classification systems.

Url:
DOI: 10.1111/bpa.12050

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:5B444A4327C13DDAA09AA7F6A766BDF5A6B00818

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Histological Predictors of Outcome in Ependymoma are Dependent on Anatomic Site Within the Central Nervous System</title>
<author>
<name sortKey="Raghunathan, Aditya" sort="Raghunathan, Aditya" uniqKey="Raghunathan A" first="Aditya" last="Raghunathan">Aditya Raghunathan</name>
</author>
<author>
<name sortKey="Wani, Khalida" sort="Wani, Khalida" uniqKey="Wani K" first="Khalida" last="Wani">Khalida Wani</name>
</author>
<author>
<name sortKey="Armstrong, Terri S" sort="Armstrong, Terri S" uniqKey="Armstrong T" first="Terri S." last="Armstrong">Terri S. Armstrong</name>
</author>
<author>
<name sortKey="Vera Olanos, Elizabeth" sort="Vera Olanos, Elizabeth" uniqKey="Vera Olanos E" first="Elizabeth" last="Vera-Bolanos">Elizabeth Vera-Bolanos</name>
</author>
<author>
<name sortKey="Fouladi, Maryam" sort="Fouladi, Maryam" uniqKey="Fouladi M" first="Maryam" last="Fouladi">Maryam Fouladi</name>
</author>
<author>
<name sortKey="Gilbertson, Richard" sort="Gilbertson, Richard" uniqKey="Gilbertson R" first="Richard" last="Gilbertson">Richard Gilbertson</name>
</author>
<author>
<name sortKey="Gajjar, Amar" sort="Gajjar, Amar" uniqKey="Gajjar A" first="Amar" last="Gajjar">Amar Gajjar</name>
</author>
<author>
<name sortKey="Goldman, Stewart" sort="Goldman, Stewart" uniqKey="Goldman S" first="Stewart" last="Goldman">Stewart Goldman</name>
</author>
<author>
<name sortKey="Lehman, Norman L" sort="Lehman, Norman L" uniqKey="Lehman N" first="Norman L." last="Lehman">Norman L. Lehman</name>
</author>
<author>
<name sortKey="Metellus, Phillipe" sort="Metellus, Phillipe" uniqKey="Metellus P" first="Phillipe" last="Metellus">Phillipe Metellus</name>
</author>
<author>
<name sortKey="Mikkelsen, Tom" sort="Mikkelsen, Tom" uniqKey="Mikkelsen T" first="Tom" last="Mikkelsen">Tom Mikkelsen</name>
</author>
<author>
<name sortKey="Necesito Eyes, Mary Jo T" sort="Necesito Eyes, Mary Jo T" uniqKey="Necesito Eyes M" first="Mary Jo T." last="Necesito-Reyes">Mary Jo T. Necesito-Reyes</name>
</author>
<author>
<name sortKey="Omuro, Antonio" sort="Omuro, Antonio" uniqKey="Omuro A" first="Antonio" last="Omuro">Antonio Omuro</name>
</author>
<author>
<name sortKey="Packer, Roger J" sort="Packer, Roger J" uniqKey="Packer R" first="Roger J." last="Packer">Roger J. Packer</name>
</author>
<author>
<name sortKey="Partap, Sonia" sort="Partap, Sonia" uniqKey="Partap S" first="Sonia" last="Partap">Sonia Partap</name>
</author>
<author>
<name sortKey="Pollack, Ian F" sort="Pollack, Ian F" uniqKey="Pollack I" first="Ian F." last="Pollack">Ian F. Pollack</name>
</author>
<author>
<name sortKey="Prados, Michael D" sort="Prados, Michael D" uniqKey="Prados M" first="Michael D." last="Prados">Michael D. Prados</name>
</author>
<author>
<name sortKey="Robins, H Ian" sort="Robins, H Ian" uniqKey="Robins H" first="H. Ian" last="Robins">H. Ian Robins</name>
</author>
<author>
<name sortKey="Soffietti, Riccardo" sort="Soffietti, Riccardo" uniqKey="Soffietti R" first="Riccardo" last="Soffietti">Riccardo Soffietti</name>
</author>
<author>
<name sortKey="Wu, Jing" sort="Wu, Jing" uniqKey="Wu J" first="Jing" last="Wu">Jing Wu</name>
</author>
<author>
<name sortKey="Miller, C Ryan" sort="Miller, C Ryan" uniqKey="Miller C" first="C. Ryan" last="Miller">C. Ryan Miller</name>
</author>
<author>
<name sortKey="Gilbert, Mark R" sort="Gilbert, Mark R" uniqKey="Gilbert M" first="Mark R." last="Gilbert">Mark R. Gilbert</name>
</author>
<author>
<name sortKey="Aldape, Kenneth D" sort="Aldape, Kenneth D" uniqKey="Aldape K" first="Kenneth D." last="Aldape">Kenneth D. Aldape</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5B444A4327C13DDAA09AA7F6A766BDF5A6B00818</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1111/bpa.12050</idno>
<idno type="url">https://api.istex.fr/document/5B444A4327C13DDAA09AA7F6A766BDF5A6B00818/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001499</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001499</idno>
<idno type="wicri:Area/Istex/Curation">001499</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D28</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D28</idno>
<idno type="wicri:doubleKey">1015-6305:2013:Raghunathan A:histological:predictors:of</idno>
<idno type="wicri:Area/Main/Merge">006318</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Histological Predictors of Outcome in Ependymoma are Dependent on Anatomic Site Within the Central Nervous System</title>
<author>
<name sortKey="Raghunathan, Aditya" sort="Raghunathan, Aditya" uniqKey="Raghunathan A" first="Aditya" last="Raghunathan">Aditya Raghunathan</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<wicri:orgArea>The University of Texas MD Anderson Cancer Center, TX</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Wani, Khalida" sort="Wani, Khalida" uniqKey="Wani K" first="Khalida" last="Wani">Khalida Wani</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<wicri:orgArea>The University of Texas MD Anderson Cancer Center, TX</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Armstrong, Terri S" sort="Armstrong, Terri S" uniqKey="Armstrong T" first="Terri S." last="Armstrong">Terri S. Armstrong</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<wicri:orgArea>The University of Texas MD Anderson Cancer Center, TX</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Vera Olanos, Elizabeth" sort="Vera Olanos, Elizabeth" uniqKey="Vera Olanos E" first="Elizabeth" last="Vera-Bolanos">Elizabeth Vera-Bolanos</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<wicri:orgArea>The University of Texas MD Anderson Cancer Center, TX</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Fouladi, Maryam" sort="Fouladi, Maryam" uniqKey="Fouladi M" first="Maryam" last="Fouladi">Maryam Fouladi</name>
<affiliation>
<wicri:noCountry code="subField">Cincinnati</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Gilbertson, Richard" sort="Gilbertson, Richard" uniqKey="Gilbertson R" first="Richard" last="Gilbertson">Richard Gilbertson</name>
<affiliation>
<wicri:noCountry code="subField">Memphis</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Gajjar, Amar" sort="Gajjar, Amar" uniqKey="Gajjar A" first="Amar" last="Gajjar">Amar Gajjar</name>
<affiliation>
<wicri:noCountry code="subField">Memphis</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Goldman, Stewart" sort="Goldman, Stewart" uniqKey="Goldman S" first="Stewart" last="Goldman">Stewart Goldman</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">Chicago</settlement>
<region type="state">Illinois</region>
</placeName>
<wicri:orgArea>Northwestern University, IL</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Lehman, Norman L" sort="Lehman, Norman L" uniqKey="Lehman N" first="Norman L." last="Lehman">Norman L. Lehman</name>
<affiliation>
<wicri:noCountry code="subField">Detroit</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Metellus, Phillipe" sort="Metellus, Phillipe" uniqKey="Metellus P" first="Phillipe" last="Metellus">Phillipe Metellus</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Timone University Hospital, Marseille</wicri:regionArea>
<placeName>
<region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mikkelsen, Tom" sort="Mikkelsen, Tom" uniqKey="Mikkelsen T" first="Tom" last="Mikkelsen">Tom Mikkelsen</name>
<affiliation>
<wicri:noCountry code="subField">Detroit</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Necesito Eyes, Mary Jo T" sort="Necesito Eyes, Mary Jo T" uniqKey="Necesito Eyes M" first="Mary Jo T." last="Necesito-Reyes">Mary Jo T. Necesito-Reyes</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<wicri:orgArea>The University of Texas MD Anderson Cancer Center, TX</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Omuro, Antonio" sort="Omuro, Antonio" uniqKey="Omuro A" first="Antonio" last="Omuro">Antonio Omuro</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Memorial Sloan‐Kettering Cancer Center, NY</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Packer, Roger J" sort="Packer, Roger J" uniqKey="Packer R" first="Roger J." last="Packer">Roger J. Packer</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
<wicri:cityArea>Children's National Medical Center, DC</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Partap, Sonia" sort="Partap, Sonia" uniqKey="Partap S" first="Sonia" last="Partap">Sonia Partap</name>
<affiliation>
<wicri:noCountry code="subField">Alto</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Pollack, Ian F" sort="Pollack, Ian F" uniqKey="Pollack I" first="Ian F." last="Pollack">Ian F. Pollack</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:orgArea>Children's Hospital of Pittsburgh, PA</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Prados, Michael D" sort="Prados, Michael D" uniqKey="Prados M" first="Michael D." last="Prados">Michael D. Prados</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>University of California San Francisco, CA</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Robins, H Ian" sort="Robins, H Ian" uniqKey="Robins H" first="H. Ian" last="Robins">H. Ian Robins</name>
<affiliation>
<wicri:noCountry code="subField">Madison</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Soffietti, Riccardo" sort="Soffietti, Riccardo" uniqKey="Soffietti R" first="Riccardo" last="Soffietti">Riccardo Soffietti</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Torino and San Giovanni Battista Hospital, Turin</wicri:regionArea>
<placeName>
<settlement type="city">Turin</settlement>
<region type="région" nuts="2">Piémont</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wu, Jing" sort="Wu, Jing" uniqKey="Wu J" first="Jing" last="Wu">Jing Wu</name>
<affiliation>
<wicri:noCountry code="subField">Hill</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Miller, C Ryan" sort="Miller, C Ryan" uniqKey="Miller C" first="C. Ryan" last="Miller">C. Ryan Miller</name>
<affiliation>
<wicri:noCountry code="subField">Hill</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Gilbert, Mark R" sort="Gilbert, Mark R" uniqKey="Gilbert M" first="Mark R." last="Gilbert">Mark R. Gilbert</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<wicri:orgArea>The University of Texas MD Anderson Cancer Center, TX</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Aldape, Kenneth D" sort="Aldape, Kenneth D" uniqKey="Aldape K" first="Kenneth D." last="Aldape">Kenneth D. Aldape</name>
<affiliation wicri:level="3">
<country>États-Unis</country>
<placeName>
<settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<wicri:orgArea>The University of Texas MD Anderson Cancer Center, TX</wicri:orgArea>
</affiliation>
<affiliation></affiliation>
<affiliation>
<wicri:noCountry code="no comma">E-mail: kaldape@mdanderson.org</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Brain Pathology</title>
<title level="j" type="alt">BRAIN PATHOLOGY</title>
<idno type="ISSN">1015-6305</idno>
<idno type="eISSN">1750-3639</idno>
<imprint>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="584">584</biblScope>
<biblScope unit="page" to="594">594</biblScope>
<biblScope unit="page-count">11</biblScope>
<date type="published" when="2013-09">2013-09</date>
</imprint>
<idno type="ISSN">1015-6305</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1015-6305</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acta neuropathol</term>
<term>Additional radiation</term>
<term>Adjacent tissue</term>
<term>Adjuvant</term>
<term>Adult patients</term>
<term>Anaplasia</term>
<term>Anaplastic</term>
<term>Anaplastic ependymomas</term>
<term>Anatomic</term>
<term>Anatomic site</term>
<term>Brain pathology</term>
<term>Canal</term>
<term>Chemotherapy</term>
<term>Chemotherapy information</term>
<term>Clinical factors</term>
<term>Different compartments</term>
<term>Distinct groups</term>
<term>Ependymal</term>
<term>Ependymal canals</term>
<term>Ependymoma</term>
<term>Ependymoma raghunathan</term>
<term>Ependymomas</term>
<term>Ependymomas patient population</term>
<term>Extensive ependymal canals</term>
<term>Focal areas</term>
<term>Fossa</term>
<term>Guideline</term>
<term>Histological</term>
<term>Histological features</term>
<term>Histological score</term>
<term>Histology</term>
<term>Hypercellular</term>
<term>Hypercellular areas</term>
<term>Hypercellularity</term>
<term>Individual histological factors</term>
<term>Individual histological features</term>
<term>Infratentorial ependymomas</term>
<term>Initial diagnosis</term>
<term>International society</term>
<term>Intracranial</term>
<term>Intracranial ependymoma</term>
<term>Intracranial ependymomas</term>
<term>Last contact</term>
<term>Metagene</term>
<term>Microvascular</term>
<term>Microvascular proliferation</term>
<term>Mitotic</term>
<term>Mitotic rate</term>
<term>Multivariate</term>
<term>Multivariate analysis</term>
<term>Necrosis</term>
<term>Neuropathology</term>
<term>Neuropathology raghunathan</term>
<term>Papillary structures</term>
<term>Patient outcomes</term>
<term>Pediatric</term>
<term>Pediatric patients</term>
<term>Posterior fossa</term>
<term>Prognostic</term>
<term>Prognostic factors</term>
<term>Progressionfree survival</term>
<term>Proliferation</term>
<term>Pseudorosettes</term>
<term>Radiation therapy</term>
<term>Raghunathan</term>
<term>Recurrence</term>
<term>Regression analyses</term>
<term>Regression analysis</term>
<term>Resection</term>
<term>Spinal</term>
<term>Spinal cord</term>
<term>Spinal cord compartments</term>
<term>Study population</term>
<term>Subtotal resections</term>
<term>Supratentorial</term>
<term>Supratentorial ependymomas</term>
<term>Surgical resection</term>
<term>Survival curves</term>
<term>Tumor necrosis</term>
<term>Tumor recurrence</term>
<term>Univariate</term>
<term>Univariate analysis</term>
<term>World health organization grade</term>
<term>Worse outcome</term>
<term>Worse survival</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acta neuropathol</term>
<term>Additional radiation</term>
<term>Adjacent tissue</term>
<term>Adjuvant</term>
<term>Adult patients</term>
<term>Anaplasia</term>
<term>Anaplastic</term>
<term>Anaplastic ependymomas</term>
<term>Anatomic</term>
<term>Anatomic site</term>
<term>Brain pathology</term>
<term>Canal</term>
<term>Chemotherapy</term>
<term>Chemotherapy information</term>
<term>Clinical factors</term>
<term>Different compartments</term>
<term>Distinct groups</term>
<term>Ependymal</term>
<term>Ependymal canals</term>
<term>Ependymoma</term>
<term>Ependymoma raghunathan</term>
<term>Ependymomas</term>
<term>Ependymomas patient population</term>
<term>Extensive ependymal canals</term>
<term>Focal areas</term>
<term>Fossa</term>
<term>Guideline</term>
<term>Histological</term>
<term>Histological features</term>
<term>Histological score</term>
<term>Histology</term>
<term>Hypercellular</term>
<term>Hypercellular areas</term>
<term>Hypercellularity</term>
<term>Individual histological factors</term>
<term>Individual histological features</term>
<term>Infratentorial ependymomas</term>
<term>Initial diagnosis</term>
<term>International society</term>
<term>Intracranial</term>
<term>Intracranial ependymoma</term>
<term>Intracranial ependymomas</term>
<term>Last contact</term>
<term>Metagene</term>
<term>Microvascular</term>
<term>Microvascular proliferation</term>
<term>Mitotic</term>
<term>Mitotic rate</term>
<term>Multivariate</term>
<term>Multivariate analysis</term>
<term>Necrosis</term>
<term>Neuropathology</term>
<term>Neuropathology raghunathan</term>
<term>Papillary structures</term>
<term>Patient outcomes</term>
<term>Pediatric</term>
<term>Pediatric patients</term>
<term>Posterior fossa</term>
<term>Prognostic</term>
<term>Prognostic factors</term>
<term>Progressionfree survival</term>
<term>Proliferation</term>
<term>Pseudorosettes</term>
<term>Radiation therapy</term>
<term>Raghunathan</term>
<term>Recurrence</term>
<term>Regression analyses</term>
<term>Regression analysis</term>
<term>Resection</term>
<term>Spinal</term>
<term>Spinal cord</term>
<term>Spinal cord compartments</term>
<term>Study population</term>
<term>Subtotal resections</term>
<term>Supratentorial</term>
<term>Supratentorial ependymomas</term>
<term>Surgical resection</term>
<term>Survival curves</term>
<term>Tumor necrosis</term>
<term>Tumor recurrence</term>
<term>Univariate</term>
<term>Univariate analysis</term>
<term>World health organization grade</term>
<term>Worse outcome</term>
<term>Worse survival</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Adjuvant</term>
<term>Histologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Ependymomas originate in posterior fossa (PF), supratentorial (ST) or spinal cord (SC) compartments. At present, grading schemes are applied independent of anatomic site. We performed detailed histological examination on 238 World Health Organization grade II and III ependymomas. Among PF ependymomas, the presence of hypercellular areas, necrosis, microvascular proliferation and elevated mitotic rate (all P < 0.01) were significantly associated with worse progression‐free survival (PFS), while extensive ependymal canal formation was not (P = 0.89). Similar to the PF tumors, microvascular proliferation (P = 0.01) and elevated mitotic rate (P = 0.03) were significantly associated with worse PFS in the ST tumors. However, in contrast to PF tumors, extensive ependymal canals (P = 0.03) were associated with worse clinical outcome in ST ependymomas, but hypercellularity (P = 0.57) and necrosis (P = 0.47) were not. On multivariate Cox regression, after adjusting for relevant clinical variables, individual histological factors and a composite histological score remained significant among ST and PF ependymoma. In contrast to both PF and ST ependymoma, histological features were not found to be associated with PFS in SC tumors. Taken together, the clinical relevance of specific histological features in ependymoma appears to be related to the anatomic site of origin and suggests that site‐specific grading criteria be considered in future classification systems.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006318 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 006318 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:5B444A4327C13DDAA09AA7F6A766BDF5A6B00818
   |texte=   Histological Predictors of Outcome in Ependymoma are Dependent on Anatomic Site Within the Central Nervous System
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021